NiO and Co 3O 4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis

European Respiratory Journal

Volumn 39, Issue 3, 2012, Pages 546-557

  Cho, W S ^a,c   Duffin, R ^a   Bradley, M ^a   Megson, I L ^b   MacNee, W ^a   Howie, S E M ^a   Donaldson, K ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF THE HIGHLANDS AND ISLANDS   (United Kingdom)

^c Dong A University   (South Korea)

Author keywords

Delayed type hypersensitivity; Hapten; Metal oxide nanoparticles; Pulmonary alveolar proteinosis; Rat

Indexed keywords

AUTOANTIBODY; CHROMIUM; COBALT; COPPER OXIDE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; HAPTEN; INTERLEUKIN 12P40; INTERLEUKIN 17; KI 67 ANTIGEN; METAL NANOPARTICLE; MONOCYTE CHEMOTACTIC PROTEIN 1; NICKEL; CHROMIC OXIDE; CHROMIUM DERIVATIVE; COBALT OXIDE; COPPER; CUPRIC OXIDE; CYTOKINE; LUNG SURFACTANT; NICKEL MONOXIDE; OXIDE;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CELL PROLIFERATION; CHRONIC TOXICITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE ASSOCIATION; FEMALE; IMMUNOREACTIVITY; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TH1 CELL; TH17 CELL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; FOREIGN BODY REACTION; IMMUNOLOGY; LUNG; LUNG LAVAGE; METABOLISM; PATHOLOGY; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL PROLIFERATION; CELLS, CULTURED; CHROMIUM COMPOUNDS; COBALT; COPPER; CYTOKINES; FEMALE; FOREIGN-BODY REACTION; HYPERSENSITIVITY, DELAYED; LUNG; MACROPHAGES, ALVEOLAR; METAL NANOPARTICLES; NICKEL; OXIDES; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY SURFACTANTS; RATS; RATS, WISTAR;

EID: 84860330280     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00047111     Document Type: Article

References (42)

1. Lu S, Duffin R, Poland C, et al. Efficacy of simple short-term in vitro assays for predicting the potential of metal oxide nanoparticles to cause pulmonary inflammation. Environ Health Perspect 2009; 117: 241-247.
2. McNeilly JD, Heal MR, Beverland IJ, et al. Soluble transition metals cause the pro-inflammatory effects of welding fumes in vitro. Toxicol Appl Pharmacol 2004; 196: 95-107. (Pubitemid 38393697)
3. Kobayashi K, Kaneda K, Kasama T. Immunopathogenesis of delayed-type hypersensitivity. Microsc Res Tech 2001; 53: 241-245. (Pubitemid 32467161)
4. Rajesh D, Zhou Y, Jankowska-Gan E, et al. Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rcnull mice. Hum Immunol 2010; 71: 551-559.
5. Sakai M, Yamashita K, Takemoto N, et al. Diesel exhaust (DE) aggravates pathology of delayed-type hypersensitivity (DTH) induced by methyl-bovine serum albumin (mBSA) in mice. J Toxicol Sci 2009; 34: 483-492.
6. Thierse HJ, Gamerdinger K, Junkes C, et al. T cell receptor (TCR) interaction with haptens: metal ions as non-classical haptens. Toxicology 2005; 209: 101-107. (Pubitemid 40568635)
7. Martin SF. T lymphocyte-mediated immune responses to chemical haptens and metal ions: implications for allergic and autoimmune disease. Int Arch Allergy Immunol 2004; 134: 186-198. (Pubitemid 38813031)
8. Budinger L, Hertl M. Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview. Allergy 2000; 55: 108-115. (Pubitemid 30106015)
9. Imanishi T, Hasegawa M, Sudo A. Serum metal ion levels after second-generation metal-on-metal total hip arthroplasty. Arch Orthop Trauma Surg 2010; 130: 1447-1450.
10. Costabel U, Nakata K. Pulmonary alveolar proteinosis associated with dust inhalation: not secondary but autoimmune? Am J Respir Crit Care Med 2010; 181: 427-428.
11. Shah PL, Hansell D, Lawson PR, et al. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 2000; 55: 67-77. (Pubitemid 30248782)
12. Cho WS, Duffin R, Poland CA, et al. Metal oxide nanoparticles induce unique inflammatory footprints in the lung; important implications for nanoparticle testing. Environ Health Perspect 2010; 118: 1699-1706.
13. Trapnell BC, Carey BC, Uchida K, et al. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Curr Opin Immunol 2009; 21: 514-521.
14. Stopford W, Turner J, Cappellini D, et al. Bioaccessibility testing of cobalt compounds. J Environ Monit 2003; 5: 675-680. (Pubitemid 36981218)
15. Moss OR. Simulants of lung interstitial fluid. Health Phys 1979; 36: 447-448. (Pubitemid 9218628)
16. Trapnell BC, Whitsett JA. GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 2002; 64: 775-802. (Pubitemid 34259249)
17. Tonks A, Parton J, Tonks AJ, et al. Surfactant phospholipid DPPC downregulates monocyte respiratory burst via modulation of PKC. Am J Physiol Lung Cell Mol Physiol 2005; 288: L1070-L1080. (Pubitemid 40695432)
18. Yee M, Vitiello PF, Roper JM, et al. Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development. Am J Physiol Lung Cell Mol Physiol 2006; 291: L1101-L1111. (Pubitemid 44772072)
19. Ogami A, Morimoto Y, Myojo T, et al. Pathological features of different sizes of nickel oxide following intratracheal instillation in rats. Inhal Toxicol 2009; 21: 812-818.
20. Duffin R, Tran L, Brown D, et al. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 2007; 19: 849-856. (Pubitemid 47237750)
21. Yokohira M, Kuno T, Yamakawa K, et al. Lung toxicity of 16 fine particles on intratracheal instillation in a bioassay model using f344 male rats. Toxicol Pathol 2008; 36: 620-631.
22. Nyberg K, Johansson U, Johansson A, et al. Phagolysosomal pH in alveolar macrophages. Environ Health Perspect 1992; 97: 149-152.
23. Hirano S, Ebihara H, Sakai S, et al. Pulmonary clearance and toxicity of intratracheally instilled cupric oxide in rats. Arch Toxicol 1993; 67: 312-317. (Pubitemid 23180976)
24. Benson JM, Chang IY, Cheng YS, et al. Particle clearance and histopathology in lungs of F344/N rats and B6C3F1 mice inhaling nickel oxide or nickel sulfate. Fundam Appl Toxicol 1995; 28: 232-244. (Pubitemid 26018564)
25. Benson JM, Barr EB, Bechtold WE, et al. Fate of inhaled nickel oxide and nickel subsulfide in F344/N rats. Inhal Toxicol 1994; 6: 167-183. (Pubitemid 2079156)
26. Oyabu T, Ogami A, Morimoto Y, et al. Biopersistence of inhaled nickel oxide nanoparticles in rat lung. Inhal Toxicol 2007; 19: Suppl. 1, 55-58. (Pubitemid 47450709)
27. Cassee FR, Muijser H, Duistermaat E, et al. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch Toxicol 2002; 76: 277-286. (Pubitemid 34639523)
28. Environmental Protection Agency. Nickel Compounds. www.epa. gov/ttn/atw/hlthef/nickel.html Date last updated: November 2007. Date last accessed: January 2012.
29. Boring L, Gosling J, Chensue SW, et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997; 100: 2552-2561. (Pubitemid 27514895)
30. Maus U, von Grote K, Kuziel WA, et al. The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am J Respir Crit Care Med 2002; 166: 268-273. (Pubitemid 34864412)
31. Carr MW, Roth SJ, Luther E, et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994; 91: 3652-3656. (Pubitemid 24139489)
32. Fitch PM, Wheelhouse NM, Bowles P, et al. Ectopic lymphoid tissue formation in the lungs of mice infected with Chlamydia pneumoniae is associated with epithelial macrophage inflammatory protein-2/CXCL2 expression. Clin Exp Immunol 2010; 162: 372-378.
33. Meyts I, Hellings PW, Hens G, et al. IL-12 contributes to allergen-induced airway inflammation in experimental asthma. J Immunol 2006; 177: 6460-6470. (Pubitemid 44628865)
34. Bai H, Cheng J, Gao X, et al. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol 2009; 183: 5886-5895.
35. Sakagami T, Beck D, Uchida K, et al. Patient-derived granulocyte/ macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med 2010; 182: 49-61.
36. Corrin B, King E. Pathogenesis of experimental pulmonary alveolar proteinosis. Thorax 1970; 25: 230-236.
37. Cummings KJ, Donat WE, Ettensohn DB, et al. Pulmonary alveolar proteinosis in workers at an indium processing facility. Am J Respir Crit Care Med 2010; 181: 458-464.
38. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008; 177: 752-762. (Pubitemid 351490562)
39. National Toxicology Program. NTP toxicology and carcinogenesis studies of nickel oxide (CAS No. 1313-99-1) in F344 rats and B6C3F1 mice (inhalation studies). Natl Toxicol Program Tech Rep Ser 1996; 451: 1-381.
40. National Toxicology Program. NTP toxicology and carcinogenesis studies of nickel subsulfide (CAS No. 12035-72-2) in F344 rats and B6C3F1 mice (inhalation studies). Natl Toxicol Program Tech Rep Ser 1996; 453: 1-365.
41. National Toxicology Program. NTP toxicology and carcinogenesis studies of nickel sulfate hexahydrate (CAS No. 10101-97-0) in F344 rats and B6C3F1 mice (inhalation studies). Natl Toxicol Program Tech Rep Ser 1996; 454: 1-380.
42. Borm PJ, Robbins D, Haubold S, et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 2006; 3: 11.